K172216

Substantially Equivalent

ACIST RXi Mini System

Applicant: Acist Medical Systems, Inc.
Product code: DRQ
Advisory panel: Cardiovascular
Date received: 2017-07-24
Decision date: 2017-08-18
Decision: Substantially Equivalent
Clearance type: Special
Location: Eden Prairie, MN, US

Download summary PDF View on FDA.gov ↗

Data sourced from openFDA. This site is unofficial and independent of the FDA.